PIK3CA and neoplasm: Mutations in the PIK3CA gene with a mutation rate from 11% to 75% [3,4,8,11,13,14,16,39] typically result in increased PI3K enzyme activity, driving sustained tumor cell growth and proliferation while inhibiting apoptosis, thus conferring a growth advantage to the tumor cells.